1. Arikan-Soylemez, Evrim Suna, Çilekar, Murat, Akici, Murat, Söylemez, Zafer, Solak, Mustafa. . Investigation of the IL7Rα Gene Polymorphism rs6897932 and the Expression Levels of the CDH1, TTPAL, and FHIT Genes in Patients with Breast Cancer. In Puerto Rico health sciences journal, 42, 283-290. doi:. https://pubmed.ncbi.nlm.nih.gov/38104284/
2. Liu, Wenxiu, Gou, Hongyan, Wang, Xiaohong, Li, Shengmian, Yu, Jun. 2021. TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling. In Oncogene, 40, 6666-6679. doi:10.1038/s41388-021-01838-x. https://pubmed.ncbi.nlm.nih.gov/34642500/
3. Gou, Hongyan, Liang, Jessie Qiaoyi, Zhang, Lijing, Fang, Jing-Yuan, Yu, Jun. 2019. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling. In Cancer research, 79, 3332-3346. doi:10.1158/0008-5472.CAN-18-2986. https://pubmed.ncbi.nlm.nih.gov/31018940/
4. Qu, Ying, Zhang, Shuying, Qu, Yanzhang, Huang, Tianjiao, Zhou, Hong. 2020. Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia. In Frontiers in genetics, 11, 566024. doi:10.3389/fgene.2020.566024. https://pubmed.ncbi.nlm.nih.gov/33193652/
5. Arıkan Söylemez, Evrim Suna Suna, Söylemez, Zafer, Çilekar, Murat, Kenger, İbrahim Halil, Solak, Mustafa. 2022. Investigation of the expression levels of CDH1, FHIT, PTEN, and TTPAL genes in colorectal tumors. In Turkish journal of medical sciences, 52, 124-130. doi:10.3906/sag-2110-296. https://pubmed.ncbi.nlm.nih.gov/36161592/
6. Taank, Y, Agnihotri, N. 2021. Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 23, 2448-2459. doi:10.1007/s12094-021-02686-7. https://pubmed.ncbi.nlm.nih.gov/34426910/
7. Tuupanen, S, Hänninen, U A, Kondelin, J, Pitkänen, E, Aaltonen, L A. 2014. Identification of 33 candidate oncogenes by screening for base-specific mutations. In British journal of cancer, 111, 1657-62. doi:10.1038/bjc.2014.429. https://pubmed.ncbi.nlm.nih.gov/25117815/